Healthcare -
Biotechnology - NASDAQ - US
$ 64.63
-2.64 %
$ 4.11 B
Market Cap
-14.45
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Rhythm Pharmaceuticals, Inc.
| Net Income | -261 M |
| Depreciation & Amortization | 1.56 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 39.7 M |
| Change in Working Capital | 10.6 M |
| Others | 97.3 M |
| Free Cash Flow | -114 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (260.6) | (184.7) | (181.1) | (69.6) | (134.0) | (140.7) | (74.1) | (33.7) | (25.9) | (11.1) | (6.5) | (21.4) | (18.1) |
| Depreciation & Amortization | 1.6 | 1.8 | 1.7 | 1.2 | 0.7 | 0.8 | 0.4 | 0.2 | 0.1 | 0 | 0 | 20 K | 17 K |
| Deferred Income Tax | 0 | 0 | 0 | (100.0) | 0 | 0 | 0 | 1.9 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 39.7 | 32.6 | 19.8 | 20.8 | 17.5 | 11.9 | 6.4 | 2.3 | 1.2 | 0.3 | 66 K | 0.1 | 0 |
| Other Operating Activities | 94.9 | 9.4 | 5.9 | (0.2) | (0.2) | 0.2 | 4.5 | 76 K | 11 K | 1.4 | (0.3) | 0.3 | 82 K |
| Change in Working Capital | 10.6 | 4.8 | (19.7) | 1.9 | (5.9) | 5.1 | 0.7 | 39 K | 1.3 | 2.4 | (0.8) | 2.0 | 0.2 |
| Cash From Operations | (113.9) | (136.2) | (173.4) | (146.0) | (122.0) | (122.8) | (62.1) | (29.5) | (23.2) | (7.0) | (7.5) | (19.2) | (17.8) |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | 0 | 47 K | (4.3) | (5.4) | (0.2) | (3.4) | (0.7) | (0.1) | (1.1) | 17 K | 0 | 0 | 0 |
| Other Items | (48.2) | (5.6) | 32.3 | (56.7) | 158.7 | (24.6) | (86.4) | (109.9) | (4.1) | 0 | 0 | (5.1) | (5.3) |
| Cash From Investing Activities | (48.2) | (5.7) | 28.0 | (62.2) | 158.5 | (28.0) | (87.1) | (110.0) | (5.1) | 17 K | 0 | (5.1) | (5.3) |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (4.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 138.8 | 25.5 | 82.7 | 4.8 | 2.0 | 2.1 | 1.8 | 41.5 | 0 | 41.7 | 7.4 | 19.9 | 22.4 |
| Cash From Financing Activities | 191.2 | 74.4 | 213.8 | 166.5 | 2.0 | 163.5 | 164.7 | 167.2 | 0 | 41.7 | 7.4 | 19.9 | 22.4 |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | 29.2 | (67.6) | 68.4 | (41.7) | 38.6 | 12.8 | 15.5 | 27.7 | (28.3) | 34.7 | 89 K | (4.4) | (0.7) |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | (113.9) | (136.2) | (177.7) | (151.4) | (122.2) | (126.1) | (62.8) | (29.6) | (24.3) | (7.0) | (7.5) | (19.2) | (17.8) |